Ascletis announces fixed-dose combination of ASC30, once-daily oral small molecule GLP-1R agonist, and ASC39, once-daily oral small molecule amylin-selective amylin receptor agonist, for clinical development
We can think of two possible reasons: One is that primary care, general practice (GP) veterinarians, either not having ultrasound devices or not being sufficiently trained to use them for echocardiography, might have complained that the EPIC Study's requirement of having echocardiograms was discriminatory against them and in favor of the cardiologists
Attempting to use an opened pen beyond 28 days compromises both safety and treatment efficacy, making replacement necessary
Type 2 diabetes: Excess body fat, especially around the abdomen, contributes to insulin resistance and can lead to type 2 diabetes
I talked to Pfizer CEO Albert Bourla and other top execs about the data this week and the company's broader obesity strategy